UNHUNH
US • HEALTHCARE
$420.74
P/E
27.06
PEG
0.44
FCF Yield
6.1%
Rev Growth YoY
+0.4% YoY
Gross Margin
19.5%
Health Score
8/10
D/E Ratio
0.83
Confidence
MEDIUM
Business Snapshot
UnitedHealth Group operates as a diversified healthcare company, primarily providing health insurance plans through its UnitedHealthcare segment and health services through Optum. It operates in the highly regulated U.S. healthcare sector, holding a dominant position as one of the largest managed care organizations by revenue and membership. As a large-cap company with a market capitalization of $384.65B and annual revenue of $450.13B, it possesses significant financial scale. The company's defining characteristic is its vertical integration, combining a massive insurance base with a broad healthcare services platform that creates operational and competitive advantages.
Financial Health
Gross margin stands at 19.5% with a net margin of 3.1%, reflecting the thin margins typical of the managed care industry where the majority of revenue passes through to medical costs. The balance sheet is in solid shape, with a debt-to-equity ratio of 0.83x, indicating moderate leverage, though the current ratio of 0.89x suggests near-term liquidity is slightly strained...
Risk Assessment
- VALUATION — P/E of 27.06x trades at a premium to the sector average of 22x, leaving less room for multiple expansion.
- DEBT / LIQUIDITY — Current ratio of 0.89x is below 1.0x, indicating the company's short-term assets do not fully cover its short-term liabilities.
- 52-WEEK POSITION — The current price of $420.74 sits 8.9% below the 52-week high of $461.62, suggesting the stock has not fully recovered from recent volatility.
- REVENUE DECELERATION — Revenue growth of just 0.4% YoY signals a mature, slow-growth top line that limits the potential for dramatic fundamental improvement....
Gross margin stands at 19.5% with a net margin of 3.1%, reflecting the thin margins typical of the managed care industry where the majority of revenue passes through to medical costs. The balance sheet is in solid shape, with a debt-to-equity ratio of 0.83x, indicating moderate leverage, though the current ratio of 0.89x suggests near-term liquidity is slightly strained. Free cash flow is exceptionally strong at $23.61B, producing a generous 6.1% FCF yield that signals robust cash generation rather than cash burn. Overall, the company is financially healthy with ample free cash flow to support dividends, share buybacks, and reinvestment into its Optum growth engine without significant dilution risk.
- VALUATION — P/E of 27.06x trades at a premium to the sector average of 22x, leaving less room for multiple expansion. - DEBT / LIQUIDITY — Current ratio of 0.89x is below 1.0x, indicating the company's short-term assets do not fully cover its short-term liabilities. - 52-WEEK POSITION — The current price of $420.74 sits 8.9% below the 52-week high of $461.62, suggesting the stock has not fully recovered from recent volatility. - REVENUE DECELERATION — Revenue growth of just 0.4% YoY signals a mature, slow-growth top line that limits the potential for dramatic fundamental improvement.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives